Systemic Lupus Erythematous Emergence in a Multiple Sclerosis Patient Treated with Fingolimod
, 2017 Amir Neshatfar
openalex +1 more source
Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis: A Real-World Study from Jordan. [PDF]
Medicina (Kaunas)Al Anber A +6 more
europepmc +1 more source
Protective role of fingolimod (FTY720) in rats subjected to subarachnoid hemorrhage [PDF]
, 2015 Chanannait Paisansathan +3 more
core +1 more source
Fingolimod Effects on Motor Function and BDNF-TrkB Signaling in a Huntington's Mouse Model Are Disease-Stage-Dependent. [PDF]
Int J Mol SciNguyen KQ, Rymar VV, Sadikot AF.
europepmc +1 more source
Der Einfluss von Fingolimod auf die autoreaktive B-Zell-Antwort in einem B-Zell-abhängigen Mausmodell der Multiplen Sklerose [PDF]
, 2019 Quirin Notz
openalex +1 more source
Oral HPV-Related Epithelial Proliferation during Fingolimod Therapy: First Case Report and Review of the Literature. [PDF]
Head Neck PatholTikkhanarak K +6 more
europepmc +1 more source
Real-world persistence and benefit–risk profile of fingolimod over 36 months in Germany [PDF]
, 2019 Tjalf Ziemssen +11 more
openalex +1 more source
Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study [PDF]
, 2016 Veronika Tichá +3 more
openalex +1 more source
Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney Disease. [PDF]
J Cell PhysiolSkafi N +16 more
europepmc +1 more source
Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model [PDF]
, 2017 Antonio Leo +7 more
openalex +1 more source